153 related articles for article (PubMed ID: 6218753)
1. The combined effects of FUdR addition and methionine depletion on the X-chromosome fragile site.
Glover TW; Howard-Peebles PN
Am J Hum Genet; 1983 Jan; 35(1):117-22. PubMed ID: 6218753
[TBL] [Abstract][Full Text] [Related]
2. The fragile X(q27) form of X-linked mental retardation: FUdR as an inducing agent for fra(X)(q27) expression in lymphocytes, fibroblasts, and amniocytes.
Brookwell R; Daniel A; Turner G; Fishburn J
Am J Med Genet; 1982 Oct; 13(2):139-48. PubMed ID: 6215863
[TBL] [Abstract][Full Text] [Related]
3. FUdR induction of the X chromosome fragile site: evidence for the mechanism of folic acid and thymidine inhibition.
Glover TW
Am J Hum Genet; 1981 Mar; 33(2):234-42. PubMed ID: 6452060
[TBL] [Abstract][Full Text] [Related]
4. Frequency of tri- or multiradial configurations in fragile X identification.
Jenkins EC; Duncan CJ; Krawczun MS; Berns LM; Sanz MM; Brown WT
Am J Med Genet; 1986; 23(1-2):531-5. PubMed ID: 2937304
[TBL] [Abstract][Full Text] [Related]
5. The effect of caffeine on fragile X expression.
Abruzzo MA; Pettay D; Mayer M; Jacobs PA
Hum Genet; 1986 May; 73(1):20-2. PubMed ID: 2940164
[TBL] [Abstract][Full Text] [Related]
6. Fragile X expression increased by low cell-culture density.
Krawczun MS; Lele KP; Jenkins EC; Brown WT
Am J Med Genet; 1986; 23(1-2):467-73. PubMed ID: 2937301
[TBL] [Abstract][Full Text] [Related]
7. Variability of thymidylate synthase activity in whole blood cultures treated with FUdR.
Sklower SL; Jenkins EC; Anderson ML; Chan CB; Brown WT
Am J Med Genet; 1986; 23(1-2):483-90. PubMed ID: 2937302
[TBL] [Abstract][Full Text] [Related]
8. 5-Fluoro-2'-deoxyuridine induction of the fragile site on Xq28 associated with X linked mental retardation.
Tommerup N; Poulsen H; Brøndum-Nielsen K
J Med Genet; 1981 Oct; 18(5):374-6. PubMed ID: 6460104
[TBL] [Abstract][Full Text] [Related]
9. Fragile sites in human chromosomes I. The effect of methionine on the Xq fragile site.
Howard-Peebles PN; Pryor JC
Clin Genet; 1981 Apr; 19(4):228-32. PubMed ID: 6944163
[TBL] [Abstract][Full Text] [Related]
10. Fragile X expression is decreased by 5-azacytidine and S-adenosylhomocysteine.
Mixon JC; Dev VG
Am J Hum Genet; 1983 Nov; 35(6):1270-5. PubMed ID: 6196967
[TBL] [Abstract][Full Text] [Related]
11. Improved prenatal detection of fra(X)(q27.3): methods for prevention of false negatives in chorionic villus and amniotic fluid cell cultures.
Jenkins EC; Krawczun MS; Stark-Houck SL; Duncan CJ; Kunaporn S; Gu H; Schwartz-Richstein C; Howard-Peebles PN; Gross A; Sherman SL
Am J Med Genet; 1991; 38(2-3):447-52. PubMed ID: 1826813
[TBL] [Abstract][Full Text] [Related]
12. The fragile X chromosome: current methods.
Hecht F; Jacky PB; Sutherland GR
Am J Med Genet; 1982 Apr; 11(4):489-95. PubMed ID: 6211983
[No Abstract] [Full Text] [Related]
13. Enhanced sensitivity of lymphoblastoid cells from individuals carrying the mutation for the fragile X syndrome to the clastogenic effects of FUdR.
Duncan AM
Mutat Res; 1986 Mar; 173(3):201-5. PubMed ID: 2936953
[TBL] [Abstract][Full Text] [Related]
14. Cytogenetic guidelines for fragile X studies tested in routine practice.
Dewald GW; Buckley DD; Spurbeck JL; Jalal SM
Am J Med Genet; 1992 Dec; 44(6):816-21. PubMed ID: 1481854
[TBL] [Abstract][Full Text] [Related]
15. Constitutive fragile sites 1p31, 3p14, 6q26, and 16q23 and their use as controls for false-negative results with the fragile(X).
Daniel A; Ekblom L; Phillips S
Am J Med Genet; 1984 Jul; 18(3):483-91. PubMed ID: 6476008
[TBL] [Abstract][Full Text] [Related]
16. Fragile X expression in short-term whole blood cultures is affected by cell density.
Krawczun MS; Jenkins EC; Brown WT; Silverman WP
Am J Med Genet; 1988; 30(1-2):435-42. PubMed ID: 2972206
[TBL] [Abstract][Full Text] [Related]
17. Fragile (X) expression: relationship to the cell cycle.
Cantú ES; Jacobs PA
Hum Genet; 1984; 67(1):99-102. PubMed ID: 6235168
[TBL] [Abstract][Full Text] [Related]
18. Cytogenetic investigations in mentally retarded and normal males from 14 families with the fragile site at Xq28. Results of folic acid treatment on fra(X) expression.
Nielsen KB; Tommerup N
Hum Genet; 1984; 66(2-3):225-9. PubMed ID: 6232199
[TBL] [Abstract][Full Text] [Related]
19. Progress toward an internal control system for fragile-X induction by 5-fluorodeoxyuridine in whole-blood cultures.
Jenkins EC; Duncan CJ; Sanz MM; Genovese M; Gu H; Schwartz-Richstein C; Lele KP; Salandi ML; Krawczun MS
Pathobiology; 1990; 58(4):236-40. PubMed ID: 2147548
[TBL] [Abstract][Full Text] [Related]
20. Distribution of diploidy, polyploidy, and endoreduplication in fra(X) positive and negative lymphocytes, amniocytes, and chorionic villi.
Jenkins EC; Sanz MM; Ray JH; Stark-Houck SL; Brown WT
Am J Med Genet; 1991; 38(2-3):434-6. PubMed ID: 1826811
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
